Quantcast

Latest Healing Stories

2010-02-16 14:30:00

-Box office opens February 18- NEW YORK, Feb. 16 /PRNewswire-USNewswire/ -- His Holiness the Dalai Lama will visit New York City, May 20 - 23, 2010. Jointly hosted by Healing the Divide and The Tibet Center, the Dalai Lama's main activities will include a public talk and three days of Buddhist teachings, both at Radio City Music Hall. Thursday, May 20 to Saturday, May 22, 9:30 - 11:30 a.m. and 1:30 - 3:30 p.m. daily: His Holiness the Dalai Lama will teach for three days on two...

2010-02-09 08:00:00

FORT WORTH, Texas, Feb. 9 /PRNewswire/ -- Healthpoint today announced it has provided research grants to the University of Florida, Gainesville, and Vanderbilt University School of Medicine to support a joint study evaluating bioburden and potential healing markers in chronic wounds. This research initiative will explore the hypothesis that bacterial biofilms are associated with the breakdown of key components on cells and in the extracellular matrix (ECM) that regulate wound healing....

2010-01-28 08:00:00

CARLSBAD, Calif., Jan. 28 /PRNewswire/ -- Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States. This represents a significant milestone for the company as it is the second product line to be launched in the company's two year history. The initial product line, AWBAT, continues to gain adoption in burn centers throughout the US and is planned for launch in...

2010-01-26 08:00:00

FORT WORTH, Texas and PETERBOROUGH, Ontario, Jan. 26 /PRNewswire/ -- Healthpoint today announced that it will begin marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada. SANTYL® Ointment is a selective enzymatic agent indicated for debriding chronic dermal ulcers (e.g., pressure ulcers, vascular ulcers, and diabetic ulcers) and severely burned areas, and is now the only enzymatic debrider available in the Canadian market....

2010-01-21 08:00:00

FORT WORTH, Texas, Jan. 21 /PRNewswire/ -- Healthpoint today announced its acquisition of two cell-based technologies from Intercytex Limited along with the corresponding intellectual property (including patents), validated fibroblast and keratinocyte cell banks, and related production and testing equipment. Terms of the deal were not disclosed by Healthpoint. The therapeutic candidates acquired include CYZACT(TM) -- human dermal fibroblasts delivered via a fibrin sheet and produced...

2010-01-07 08:00:00

SKILLMAN, N.J., Jan. 7 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today its platinum sponsorship for the 4th Congress of the World Union of Wound Healing Societies (WUWHS), which will take place in Yokohama, Japan from September 2-7, 2012. "ConvaTec is proud to continue our long-standing support of WUWHS as a 2012 platinum sponsor and partner to clinicians engaged in acute and chronic wound...

2009-12-14 08:15:00

SAN DIEGO, Dec. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced a presentation titled, "Phase 2b Study of GAM501 (Ad5PDGF-B/Collagen) in the Treatment of Diabetic Ulcers," at the Tenth Annual Wound Healing: Science and Industry Conference held December 10-13, 2009 in St. Thomas, U.S. Virgin Islands. The conference is attended by top industry leaders and renowned researchers in the field of advanced wound healing. Dr. Barbara K. Sosnowski, Cardium's Vice...

2009-12-03 09:50:00

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) announced today that its wholly-owned subsidiary, Tissue Repair Company, submitted a 510(k) premarket notification filing with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its Excellagen(TM) product candidate based on positive data from the Company's recently completed Phase 2b Matrix clinical study. Today's submission with the FDA covers ExcellagenXL(TM) and ExcellagenFX(TM),...

2009-12-01 07:30:00

FORT WORTH, Texas, Dec. 1 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that further positive case study data on CellerateRx®, the core product of the Wound Care Innovations, LLC operating subsidiary, was released at the recent 6(th) Annual High Risk Diabetic Foot Conference for VA Podiatrists and Healthcare Professional in Tempe, AZ. One of the Wound...

2009-11-25 02:01:00

VANCOUVER, Nov. 25 /PRNewswire/ -- Adam DreamHealer's Global Intention Heals Project proved that sending healing intentions changes the physiology of someone at a distance. Over 10,000 participants sent healing intentions at a time unknown to a volunteer who was monitored by a quantitative-EEG. The data was analyzed by world experts in the USA and Canada. On November 8 in Vancouver, B.C. Adam initiated the world's largest intentional healing experiment. To focus intentions, Adam created a...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.